These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37694681)

  • 1. Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.
    Nou-Fontanet L; Martín-Gómez C; Isabel-Gómez R; Bachoud-Lévi AC; Zorzi G; Capuano A; ; Blasco-Amaro JA; Ortigoza-Escobar JD
    Eur J Neurol; 2023 Dec; 30(12):3928-3948. PubMed ID: 37694681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders.
    Nou-Fontanet L; Nguyen QTR; Bachoud-Levi AC; Reinhard C; ; Ortigoza-Escobar JD
    Eur J Paediatr Neurol; 2024 Jul; 51():110-117. PubMed ID: 38917695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.
    Gras D; Jonard L; Roze E; Chantot-Bastaraud S; Koht J; Motte J; Rodriguez D; Louha M; Caubel I; Kemlin I; Lion-François L; Goizet C; Guillot L; Moutard ML; Epaud R; Héron B; Charles P; Tallot M; Camuzat A; Durr A; Polak M; Devos D; Sanlaville D; Vuillaume I; Billette de Villemeur T; Vidailhet M; Doummar D
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):956-62. PubMed ID: 22832740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chorea due to TITF1/NKX2-1 mutation: phenotypical description and therapeutic response in a family].
    Salvado M; Boronat-Guerrero S; Hernández-Vara J; Álvarez-Sabin J
    Rev Neurol; 2013 May; 56(10):515-20. PubMed ID: 23658034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless Legs Syndrome in NKX2-1-related chorea: An expansion of the disease spectrum.
    Iodice A; Carecchio M; Zorzi G; Garavaglia B; Spagnoli C; Salerno GG; Frattini D; Mencacci NE; Invernizzi F; Veneziano L; Mantuano E; Angriman M; Fusco C
    Brain Dev; 2019 Mar; 41(3):250-256. PubMed ID: 30352709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-Thyroxine-responsive drop attacks in childhood benign hereditary chorea: A case report.
    Shiohama T; Ohashi H; Shimizu K; Fujii K; Oba D; Takatani T; Kato M; Shimojo N
    Brain Dev; 2018 Apr; 40(4):353-356. PubMed ID: 29289388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A
    Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa-Responsive Chorea: A Review.
    Farrenburg M; Gupta HV
    Ann Indian Acad Neurol; 2020; 23(2):211-214. PubMed ID: 32189864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
    Frank S; Stamler D; Kayson E; Claassen DO; Colcher A; Davis C; Duker A; Eberly S; Elmer L; Furr-Stimming E; Gudesblatt M; Hunter C; Jankovic J; Kostyk SK; Kumar R; Loy C; Mallonee W; Oakes D; Scott BL; Sung V; Goldstein J; Vaughan C; Testa CM;
    JAMA Neurol; 2017 Aug; 74(8):977-982. PubMed ID: 28692723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
    Brigo F; Igwe SC; Bragazzi NL; Lattanzi S
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013028. PubMed ID: 35187637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrabenazine: for chorea associated with Huntington's disease.
    Scott LJ
    CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
    Sung VW; Iyer RG; Gandhi SK; Shah-Manek B; DiBonaventura M; Abler V; Claassen DO
    Curr Med Res Opin; 2018 Apr; 34(4):643-648. PubMed ID: 29383957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
    Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
    J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Movement Disorder of Brain-Lung-Thyroid Syndrome Can be Responsive to Methylphenidate.
    Gauquelin L; Tran LT; Chouinard S; Bernard G
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():508. PubMed ID: 29109906
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonazepam in the treatment of choreiform activity.
    Peiris JB; Boralessa H; Lionel ND
    Med J Aust; 1976 Feb; 1(8):225-7. PubMed ID: 131236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.